Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Roivant Sciences (ROIV) has a market cap of $7.18 billion USD. According to our data, Roivant Sciences is ranked No.2049 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $7.18 B |
-16.64%
|
| Dec 31, 2024 | $8.61 B |
5.34%
|
| Dec 29, 2023 | $8.17 B |
40.55%
|
| Dec 30, 2022 | $5.82 B |
-20.73%
|
| Dec 31, 2021 | $7.34 B |
-0.88%
|
| Dec 31, 2020 | $7.40 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
| Market Cap | = | ROIV Stock Price | * | ROIV Shares Outstanding |
| = | $10.06 | * | 0.71 B | |
| = | $7.18 B |